Navigation Links
Mothers of Rebellious Teens- Blame It on THP

Mothers of teenagers may find this hard to digest, but scientists have come out with findings that puts down their ‘raging hormones' and infamous// behavior, to an unexpected chemical reaction; the effect of one specific hormone-THP.

The experiments, by Sheryl Smith, a physiologist at the State University of New York, offer the first physiological explanation for adolescent mood swings.

Smith experimented with mice by subjecting them to sources of stress, one of them being by keeping the mice in a very tiny cage for 45 minutes. She found that the reactions to stress in adolescent mice were markedly more and very different from the others. The cause,found by further experiments, was due to increased excitability brought about by the hormone THP.

Scientists say that the steroid THP acts on brain cells via molecular doorways known as receptors.

Scientists have found that the mechanism normally used by the brain to calm itself down in stressful situations appears to work in the opposite way in teenagers, making them actually more anxious.

When the brain senses a stressful situation, it reacts by switching on receptors, using a range of chemicals, including THP. In an adult or even a younger individual, THP would reduce anxiety.

During adolescence, mice have the usual receptors, but also extra-high levels of a second kind that brings an anxious, rather than calming, response when THP attaches to it, according to the researchers.

Says Smith, 'The parallel with humans is that in humans there are similar hormonal changes going on in puberty. 'So the beginning of puberty is a time when a lot of emotions and responses to stress are increased. It's nothing new that teenagers go through a difficult time.'

Smith says that while it is possible to block this particular effect of THP, it will require more research , but immediate results of the study could be in the better understanding of ‘teenageho
'"/>




Page: 1 2

Related medicine news :

1. Mothers with periodontitis may deliver premature babies
2. Changing Partners may put Expectant Mothers at Risk
3. Link Between Mothers Depression and Violence in Children
4. Depressed Mothers Found To Influence Their Child’s Behavio
5. Mothers diet in pregnancy and after can prevent daughter’s breast cancer
6. Donated Mothers Milk To Hit The Market
7. Adult Kids Of Alcoholic Mothers Face Health Risk
8. Critical Decisions Have To Be Taken By Mothers Of Premature Babies
9. Mothers Happy After Exchange Of Swapped Infants
10. Anxious Fathers Make Mothers Nervous
11. Newborns Affected By Antidepressant Intake Of Mothers
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Mothers Rebellious Teens Blame THP

(Date:8/29/2008)...ton Scientific obligation reduced from $250 to $19...tCall/ -- Boston Scientific,Corporation (NYSE: BS...f,Marshall, Texas found two patents of Medtronic, ...onduct during the prosecution of the patents,befor... A jury had previously found that certain Boston S...
(Date:8/29/2008)... Dr. Milton Owens and the Coastal C...rn California to provide protection for cash payin... the Hispanic community is benefiting. , ... 2008 -- Dr. Milton Owens and the Coastal Center f...fornia to provide protection for cash paying patie...
(Date:8/29/2008)... Trusted life science software prov...lients to engage via GSA. , ...ions, an emerging software engineering firm dedic...a U.S. General Services Administration (GSA) Contr...stomers with the ability to conveniently engage 5A...
(Date:8/28/2008)...enues increase 138% versus Q2 2007 - Nine new C.../PRNewswire-FirstCall/ - CRH Medical Corporation,(...he three and six months,ended June 30, 2008 (all f...onths ended June 30, 2008 increased 138% to $1,653...007. Revenue for the six months ended June,30, 200...
Breaking Medicine News(10 mins):Health News:Court Rejects Two Medtronic Patents 2Health News:Court Rejects Two Medtronic Patents 3Health News:Coastal Center for Obesity Offers Hispanics Weight Loss Surgery with a Warranty 2Health News:Federal and State Agencies Have Easier Access to 5AM Solutions' Award-Winning Software Services 2Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5
...h regulators, gave their nod to the first new drug...heart transplant patients.// The drug, Astellas Ph... rejection of liver and kidney transplants. Dr. S... Center for Drug Evaluation and Research said, "Th...
...dia’s population stabilization solely rests on the... which has the highest fertility rates. 'India's p...ttar Pradesh take an immediate lead in checking po...ecutive director, Population Foundation of India, ...
...rther six months of patent extension by the FDA fo...n//, Provigil. Cephlaon had complied with the te...he provision of clinical studies data after studyi...on pediatric patients. Cephalon has settled the ‘...
...ncreased risk of heart attack associated with Viox...views are 'out of the mainstream' as it is based o...Merck and Co. Thomas Cona and John Mcdarby have s...g that use of the drug had resulted in heart attac...
Other Medicine News:Health News:Doctor Grilled In Court For False Report About Vioxx Health Risk 2
(Date:8/27/2008)...prednisone arm demonstrated a, significant surviv...se -, CAMBRIDGE, Mass., Aug. 27 /- M...nced the publication of results from the 682,patie...eek,s edition of the,New England Journal of Medici...fit and a 30 percent complete remission (CR) rate ...
(Date:8/27/2008)...al, expected by mid-2009 - - Data from second Pha...CKVILLE, Md., Aug. 27 /- Hu...nnounced it has completed enrollment,and initial d... 3,randomized clinical trials of LymphoStat-B(R) (...erythematosus (SLE). Belimumab is being developed ...
(Date:8/26/2008)...mafore Pharmaceuticals Inc.,presented data at the ...es,in Cancer in Washington, D.C., announcing the d... that demonstrate significant anticancer,activity ...molecular scaffold has been developed using,comput...3 kinase inhibitors,as well as isoform-selective s...
(Date:8/26/2008)...FirstCall/ -- XTENT, Inc.,(Nasdaq: XTNT ) today a...,from the CUSTOM II trial was published in the mos...ntervention. The lead author of the article was,Dr...nter Utrecht, Utrecht,The Netherlands on behalf o...es across Europe., The one-year CUSTOM II trial, ...
Breaking Medicine Technology:New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 2New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 4New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 5New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 6Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4Older Americans are more socially engaged than many people may think 16988 1Older Americans are more socially engaged than many people may think 16988 2Older Americans are more socially engaged than many people may think 16988 3Is there anybody out there 3F 2916 1Is there anybody out there 3F 2916 255 Year Old Grandmother to Document Journey of Running Seven Marathons on Seven Continents on Run7on7 com 16984 155 Year Old Grandmother to Document Journey of Running Seven Marathons on Seven Continents on Run7on7 com 16984 255 Year Old Grandmother to Document Journey of Running Seven Marathons on Seven Continents on Run7on7 com 16984 3MEDEX Global Group Hires Industry Veteran Mike Roban as Vice President of Sales 16980 1MEDEX Global Group Hires Industry Veteran Mike Roban as Vice President of Sales 16980 2
...of Peregrine,s,Unique Selective Anti-VEGF Antibodi...l Cancer Models, TUSTIN, Calif., April 20, 2007 /P... Inc. , a clinical stage,biopharmaceutical company... treatment of cancer and hepatitis C virus infecti... presented at the recent,Centennial Annual Meeting...
...Rx Corporation,(NASDAQ:CYTR) today announced that ...clusively licensed to its majority-owned,subsidiar...,published in the April 2007 issue of peer-reviewe...hnology was developed by RXi,Co-founder, Scientifi...setts Medical School (UMMS) Professor of Biochemis...
Other Medicine Technology:Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 2Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 3Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 4Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 5Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 6Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 7CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 2CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 3CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 4
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: